{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:23:55Z","timestamp":1791591835922,"version":"4.3.4"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847845"],"award-info":[{"award-number":["847845"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2022,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We conducted a meta\u2010analysis of test agreement\/concordance between human papillomavirus (HPV) testing in self\u2010collected vs clinician\u2010collected samples in 26 studies (10\u2009071 participants) updating a previous meta\u2010analysis on accuracy for cervical precancer. Pooled overall agreement was 88.7% (95% CI: 86.3%\u201090.9%), positive agreement was 84.6% (95% CI: 79.9%\u201088.7%), negative agreement was 91.7% (95% CI: 89.1%\u201094.0%) and kappa was 0.72 (95% CI: 0.66\u20100.78). Subgroup meta\u2010analyses suggested higher overall agreement for target amplification\u2010based DNA assays (90.4%) compared to signal amplification\u2010based DNA assays (86.7%; <jats:italic>P<\/jats:italic>\u00a0=\u00a0.175) or RNA assays (82.3%; <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001). HPV test agreement\/concordance targets may provide criteria to extend existing validations toward alternative sampling approaches and devices\/storage media.<\/jats:p>","DOI":"10.1002\/ijc.33967","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T13:40:45Z","timestamp":1645191645000},"page":"308-312","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Meta\u2010analysis of agreement\/concordance statistics in studies comparing self\u2010 vs clinician\u2010collected samples for <scp>HPV<\/scp> testing in cervical cancer screening"],"prefix":"10.1002","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-5908","authenticated-orcid":false,"given":"Marc","family":"Arbyn","sequence":"first","affiliation":[{"name":"Unit of Cancer Epidemiology Sciensano, Belgian Cancer Centre  Brussels Belgium"},{"name":"Department of Human Structure and Repair, Faculty of Medicine and Health Sciences Ghent University  Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-5985","authenticated-orcid":false,"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention U.S. National Cancer Institute  Rockville Maryland USA"},{"name":"Division of Cancer Epidemiology and Genetics U.S. National Cancer Institute  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics U.S. National Cancer Institute  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-0836","authenticated-orcid":false,"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics U.S. National Cancer Institute  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Heckman\u2010Stoddard","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention U.S. National Cancer Institute  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0551-7346","authenticated-orcid":false,"given":"Vikrant V.","family":"Sahasrabuddhe","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention U.S. National Cancer Institute  Rockville Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"Access in brief: use of cervical, breast, and colon cancer tests among adult Medicaid enrollees","author":"Medicaid and CHIP Payment and Access Commission","year":"2016"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1538"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji115"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3951"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.04.004"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12628"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30763-0"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-020-01727-5"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3258-72-39"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867x0800800102"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24774"},{"key":"e_1_2_10_15_1","volume-title":"Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests\u2014Guidance for Industry and FDA Staff","author":"Food and Drug Administration, Center for Devices and Radiological Health","year":"2007"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.08.006"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.33967","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijc.33967","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.33967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T23:41:09Z","timestamp":1692315669000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.33967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,7,15]]}},"alternative-id":["10.1002\/ijc.33967"],"URL":"https:\/\/doi.org\/10.1002\/ijc.33967","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"2021-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}